Cargando…
Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain
[Image: see text] Human African Trypanosomiasis (HAT) is a neglected tropical disease widespread in sub-Saharan Africa. Rhodesain, a cysteine protease of Trypanosoma brucei rhodesiense, has been identified as a valid target for the development of anti-HAT agents. Herein, we report a series of urea-b...
Autores principales: | Previti, Santo, Ettari, Roberta, Calcaterra, Elsa, Di Chio, Carla, Ravichandran, Rahul, Zimmer, Collin, Hammerschmidt, Stefan, Wagner, Annika, Bogacz, Marta, Cosconati, Sandro, Schirmeister, Tanja, Zappalà, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290002/ https://www.ncbi.nlm.nih.gov/pubmed/35859868 http://dx.doi.org/10.1021/acsmedchemlett.2c00084 |
Ejemplares similares
-
Development of Reduced Peptide Bond Pseudopeptide Michael Acceptors for the Treatment of Human African Trypanosomiasis
por: Previti, Santo, et al.
Publicado: (2022) -
Drug Combination Studies of the Dipeptide Nitrile CD24 with Curcumin: A New Strategy to Synergistically Inhibit Rhodesain of Trypanosoma brucei rhodesiense
por: Di Chio, Carla, et al.
Publicado: (2022) -
Dipeptide Nitrile CD34 with Curcumin: A New Improved Combination Strategy to Synergistically Inhibit Rhodesain of Trypanosoma brucei rhodesiense
por: Di Chio, Carla, et al.
Publicado: (2023) -
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors
por: Previti, Santo, et al.
Publicado: (2023) -
Synthesis of Benzocycloalkanone-Based Michael Acceptors and Biological Activities as Antimalarial and Antitrypanosomal Agents
por: Mijoba, Ali, et al.
Publicado: (2023)